a year ago
NVO
AnalystsMichael NedelcovychMichael Nedelcovych's Stock Forecasts
AnalystsMichael Nedelcovych
Sectors:
Industries:
Analyst Ranking
Bottom 18%
#4605 out of 5550 analysts
Average Return
-4.79%
Win Rate
56%5 out of 9
Risk vs Reward
Poor
Good
Michael Nedelcovych's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novo Nordisk A SNVO | +48.91% | $64.91 | $96.65 | 2022-12-12 - 2023-12-11 | Buy |
Johnson & JohnsonJNJ | +12.13% | $241.30 | $270.56 | 2026-04-08 - 2026-11-02 | Strong Buy |
Royalty Pharma PLCRPRX | +9.79% | $60.59 | $66.52 | 2026-09-08 - 2026-11-02 | Strong Buy |
Novo Nordisk A SNVO | +8.20% | $100.92 | $109.20 | 2023-12-04 - 2024-12-03 | Buy |
Johnson & JohnsonJNJ | +4.96% | $257.77 | $270.56 | 2026-07-13 - 2026-11-02 | Strong Buy |
Michael Nedelcovych Analyst Color
Get additional color on Michael Nedelcovych's coverage of popular stocks
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.